Literature DB >> 9926711

[Diagnostic criteria for type 2 diabetes].

A Grimaldi1, A Heurtier.   

Abstract

A new definition of diabetes is just about to be adopted by WHO. The main change concerns the glycemic threshold for diagnosis of diabetes. Its value will decrease from 7.7 mmol/L to 7 mmol/L. This drop is neither the consequence of a methodological change (diabetes remains defined by glycemic values at risk of retinopathy) nor a revision of the gold standard (glycemic value > or = 11 mmol/L at 2 h. post glucose load remains the most accurate criterion for diagnosis). The only purpose of the new definition is to better correlate fasting glycemia with the 2 h. post load value during OGTT. So, the new definition of diabetes with a glycemic value > or = 7 mmol/L will allow to do diagnosis without OGTT. The WHO experts hope that this simplification will improve the earliness of diagnosis and treatment. WHO will propose to categorize 3 groups according to glycemic values: normal values < 6.05 mmol/L, diabetic values > 7 mmol/L, and impaired fasting glucose encompassing values above normal but below the diagnosis cut-off for diabetes (plasma glucose > or = 6.05 mmol/L to < 7.0 mmol/L). This impaired fasting glucose should be considered as a risk factor for diabetes and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9926711

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  8 in total

1.  Metformin combined with acarbose vs. single medicine in the treatment of type 2 diabetes: A meta-analysis.

Authors:  Zhongjie Liu; Xiaodong Zhao; Weiwei Sun; Yaoxian Wang; Shangjian Liu; Lei Kang
Journal:  Exp Ther Med       Date:  2017-04-13       Impact factor: 2.447

2.  ASK1-Interacting Protein 1 Acts as a Novel Predictor of Type 2 Diabetes.

Authors:  Zhigao Song; Cong Chen; Jipei He; Bixia Liu; Weidong Ji; Liangping Wu; Li He
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

3.  Serum Lipocalin-2 Levels Are Increased and Independently Associated With Early-Stage Renal Damage and Carotid Atherosclerotic Plaque in Patients With T2DM.

Authors:  Jing Gan; Yu Zheng; Qiongli Yu; Yingchao Zhang; Wei Xie; Yaru Shi; Ning Yu; Yu Yan; Zhuofeng Lin; Hong Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

4.  A meta-analysis of the association between TNF-α -308G>A polymorphism and type 2 diabetes mellitus in Han Chinese population.

Authors:  Zheng-hui Liu; Yuan-lin Ding; Liang-chang Xiu; Hai-yan Pan; Yan Liang; Shou-qiang Zhong; Wei-wei Liu; Shao-qi Rao; Dan-li Kong
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

5.  Relationship between circulating miR-132 and non-alcoholic fatty liver disease in a Chinese population.

Authors:  Yicen Zong; Jing Yan; Li Jin; Bo Xu; Zhen He; Rong Zhang; Cheng Hu; Weiping Jia
Journal:  Hereditas       Date:  2020-05-22       Impact factor: 3.271

6.  Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study.

Authors:  Weixia Jian; Wenhui Peng; Sumei Xiao; Hailing Li; Jie Jin; Li Qin; Yan Dong; Qing Su
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

7.  RNF6 Targeted by miR-26a-5p Protects Pancreatic β-Cell Function Against Type 2 Diabetes.

Authors:  Fan Yang; Shengxun Zhao; Xuyan Zhang; Sheng Ding; Yancheng Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-11       Impact factor: 3.168

8.  Association Between Uric Acid and Insulin-Like Growth Factor-1 in Type 2 Diabetes Mellitus.

Authors:  Fang Liu; Yaru Wang; Qiang Zhao; Mei Zhang; Bo Ban
Journal:  Int J Gen Med       Date:  2021-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.